Close

Registration is free and only takes a moment. If you have already registered, please log in now.

Create Account
Forgot your password?
Log In
  • Links
  • Publisher Full Text
  • Authors
  • Sekijima Y
  • MESH
  • Amyloid Neuropathies, Familial
  • Clinical Trials, Phase II as Topic
  • Clinical Trials, Phase III as Topic
  • Diflunisal
  • Gene Therapy
  • Liver Transplantation
  • Molecular Targeted Therapy
  • Prealbumin
  • Protein Folding
  • RNA, Small Interfering
  • Randomized Controlled Trials as Topic

Unbound MEDLINE

Familial amyloid polyneuropathy: diflunisal.

Links

  • Publisher Full Text
  • Authors

    Sekijima Y

    Institution

    Division of Clinical and Molecular Genetics, Shinshu University Hospital, Matsumoto, Japan.

    Source

    Rinshō shinkeigaku = Clinical neurology 50:11 2010 Nov pg 836

    MeSH

    Amyloid Neuropathies, Familial
    Clinical Trials, Phase II as Topic
    Clinical Trials, Phase III as Topic
    Diflunisal
    Gene Therapy
    Liver Transplantation
    Molecular Targeted Therapy
    Prealbumin
    Protein Folding
    RNA, Small Interfering
    Randomized Controlled Trials as Topic

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    21921462

    Related Citations

    • [Therapeutic strategy for familial amyloid polyneuropathy (FAP)].
    • [Pathogenesis and therapy for transthyretin related amyloidosis].
    • Gene therapy: lessons learned from liver transplantation for transthyretin-amyloidosis.
    • Early diagnosis and management of patients with familial ATTR amyloidosis receiving livers from asymptomatic variant TTR carriers.
    • New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    • Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    • Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses.
    • Restrictive cardiomyopathy in familial amyloidosis TTR-Arg-50.
    More
    unbound logo
    • Home »
    • Contact Us »
    • Help »
    • Privacy / Disclaimer »
    • Terms of Service »
    • Log In »
    • twitter
    • facebook
    © 2000–2013 Unbound Medicine, Inc. All rights reserved